From the monthly archives: March 2012
Aktieugebrevet skriver at Bioporto i forbindelse med årsregnskabet har fremlagt flere ting som kan rykke kursen tilbage i 9-10 stykker.
AU forventer at en aftale med en stor distributør kan være på plads til April, eller senest til Maj, og anser samtidig Roche for at være det bedste bud.
Endvidere mener AU at Bioporto kan […]
(In danish. Please use the Gtranslator tool for other languages)
Så er Bioportos præsentation klar.
Jeg kan ikke poste den da den tilhører Bioporto, men her er den.
The important thing to notice here is the green circel. The chart dosent look good, but maybe the two blue lines can predict a nye uptrend in the larger downtrend (the black lines). The MACD indicator maybe indicates an uptrend, but the SAR still says down.
Conclusion: My conclusion is still down, but […]
Symposium about NGAL at Hvidovre Hospital, Copenhagen
Senior Consultant and NGAL expert Dr. Wolfgang Huber from The Technische Universität München will give a lecture about NGAL and its application for diagnosis and management of acute kidney injury.
The symposium is organized by the Department of Clinical Biochemistry (Central lab) at Hvidovre Hospital and is intended […]
Bioporto and their patent advisor Høiberg has filed an amended set of claim in regards to the APC-PCI patent application.
The APC-PCI application can be found here.
Its worth noting the conduite that this amendment is expressing, as well as the efford being made to comply with the EPO rules and regulations, as that was […]
Jean-Michel Constantin MD, PhD et al. from Hôtel-Dieu Hospital, Clermont-Ferrand, France has made a study using the Alere (plasma)NGAL test.
The test is very much the same as always, and it declares that the NGAL test offers great potential in predicting who will develope AKI during ICU admission, and who will […]
Acording to an article printed in Clinical Chemistry and Laboratory Medicine an evaluation of The NGAL Test on the Beckman Coulter AU 5822 has been carried out.
A comparison of the results was then made with the ARCHITECT NGAL test from Abbott,
Lets skip to the result. It works just fine, or as the article puts it: “Conclusions: This […]
If you look at my chart on SPPI you can se it dosent look very well. We need to have good CUP data anytime soon. The support level is far away and the resitance is on the two green lines. But can we break the two green lines, the sky’s the limit.
Spectrum update:
In this update I will talk about the information from the two investor conferences Monday and Wednesday, and from the Q4 report and the CC. In this I will make my own analyses, I will refer to what Raj and Spectrum has been saying. So make sure before reading, some of the following […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
